Which medication is primarily used for the treatment of acute bronchospasm?

Which medication is primarily used for the treatment of acute bronchospasm?

• A. Corticosteroids
• B. B-agonists
• C. Antihistamines
• D. Anticholinergics

Answer: (B)

B-agonists are primarily used for the treatment of acute bronchospasm due to their ability to quickly relax and dilate the smooth muscles in the airways. This mechanism is essential during an acute asthma attack or other respiratory distress situations where bronchodilation is necessary to alleviate symptoms such as wheezing, coughing, and shortness of breath. Short-acting B-agonists, such as albuterol, are commonly administered through inhalers or nebulizers, providing rapid relief by acting directly on the beta-2 adrenergic receptors in the bronchial smooth muscle. This action results in the opening of the airways, making it easier for individuals to breathe. In contrast, while corticosteroids are effective for long-term management of inflammation in chronic respiratory conditions, they do not act quickly enough to provide immediate relief for acute symptoms. Antihistamines are primarily used for allergic reactions and do not generally relieve bronchospasm. Anticholinergics can help in some cases, but they are not first-line treatments for acute bronchospasm compared to B-agonists. Therefore, B-agonists are the preferred choice for immediate intervention in acute bronchospasm situations.

B-agonists are primarily used for the treatment of acute bronchospasm due to their ability to quickly relax and dilate the smooth muscles in the airways. This mechanism is essential during an acute asthma attack or other respiratory distress situations where bronchodilation is necessary to alleviate symptoms such as wheezing, coughing, and shortness of breath.

Short-acting B-agonists, such as albuterol, are commonly administered through inhalers or nebulizers, providing rapid relief by acting directly on the beta-2 adrenergic receptors in the bronchial smooth muscle. This action results in the opening of the airways, making it easier for individuals to breathe.

In contrast, while corticosteroids are effective for long-term management of inflammation in chronic respiratory conditions, they do not act quickly enough to provide immediate relief for acute symptoms. Antihistamines are primarily used for allergic reactions and do not generally relieve bronchospasm. Anticholinergics can help in some cases, but they are not first-line treatments for acute bronchospasm compared to B-agonists. Therefore, B-agonists are the preferred choice for immediate intervention in acute bronchospasm situations.